Aggregated China Media News & Blogs



AMDL Hopes For China Approval Of Anti-Cancer Drug

Aggregated Source: ChinaCSR.com
February 12, 2007|

AMDL, a developer of tests for the early detection of cancer and other serious diseases, says that Jade Pharmaceuticals, its wholly-owned subsidiary in China, has set up production and applied for China State Food and Drug Administration approval to market Docetaxel in China.

Original URL: Click here to visit original article
Copyright ChinaCSR.com
Print This Post Print This Post | Email To Friend

1 Stars2 Stars3 Stars4 Stars5 Stars6 Stars7 Stars8 Stars9 Stars10 Stars

36 Votes | Average: 3.78 out of 1036 Votes | Average: 3.78 out of 1036 Votes | Average: 3.78 out of 1036 Votes | Average: 3.78 out of 1036 Votes | Average: 3.78 out of 1036 Votes | Average: 3.78 out of 1036 Votes | Average: 3.78 out of 1036 Votes | Average: 3.78 out of 1036 Votes | Average: 3.78 out of 1036 Votes | Average: 3.78 out of 10 (36 votes, average: 3.78 out of 10)


Related Info:
  • Forum In HK to Promote Fight Against Cancer
  • Wal-Mart Continues To Support Children's Cancer Treatment In China
  • Nine Shanghai Drug Stores Asked To Rectify Business
  • Qiagen Provides Free Cervical Cancer Screening For Low-income Women
  • China SFDA Approves Clinical Trials To Combat Antibiotic Resistant Infection

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |